37333406|t|ApoER2-Dab1 disruption as the origin of pTau-related neurodegeneration in sporadic Alzheimer's disease.
37333406|a|BACKGROUND: Sporadic Alzheimer's disease (sAD) is not a global brain disease. Specific regions, layers and neurons degenerate early while others remain untouched even in advanced disease. The prevailing model used to explain this selective neurodegeneration-prion-like Tau spread-has key limitations and is not easily integrated with other defining sAD features. Instead, we propose that in humans Tau hyperphosphorylation occurs locally via disruption in ApoER2-Dab1 signaling and thus the presence of ApoER2 in neuronal membranes confers vulnerability to degeneration. Further, we propose that disruption of the Reelin/ApoE/ApoJ-ApoER2-Dab1 P85alpha-LIMK1-Tau-PSD95 (RAAAD-P-LTP) pathway induces deficits in memory and cognition by impeding neuronal lipoprotein internalization and destabilizing actin, microtubules, and synapses. This new model is based in part on our recent finding that ApoER2-Dab1 disruption is evident in entorhinal-hippocampal terminal zones in sAD. Here, we hypothesized that neurons that degenerate in the earliest stages of sAD (1) strongly express ApoER2 and (2) show evidence of ApoER2-Dab1 disruption through co-accumulation of multiple RAAAD-P-LTP components. METHODS: We applied in situ hybridization and immunohistochemistry to characterize ApoER2 expression and accumulation of RAAAD-P-LTP components in five regions that are prone to early pTau pathology in 64 rapidly autopsied cases spanning the clinicopathological spectrum of sAD. RESULTS: We found that: (1) selectively vulnerable neuron populations strongly express ApoER2; (2) numerous RAAAD P-LTP pathway components accumulate in neuritic plaques and abnormal neurons; and (3) RAAAD-P-LTP components were higher in MCI and sAD cases and correlated with histological progression and cognitive deficits. Multiplex-IHC revealed that Dab1, pP85alpha Tyr607 , pLIMK1 Thr508 , pTau and pPSD95 Thr19 accumulated together within dystrophic dendrites and soma of ApoER2-expressing neurons in the vicinity of ApoE/ApoJ enriched extracellular plaques. These observations provide evidence for molecular derangements that can be traced back to ApoER2-Dab1 disruption, in each of the sampled regions, layers, and neuron populations that are prone to early pTau pathology. CONCLUSION: Findings support the RAAAD-P-LTP hypothesis, a unifying model that implicates dendritic ApoER2-Dab1 disruption as the major driver of both pTau accumulation and neurodegeneration in sAD. This model provides a new conceptual framework to explain why specific neurons degenerate and identifies RAAAD-P-LTP pathway components as potential mechanism-based biomarkers and therapeutic targets for sAD.
37333406	0	6	ApoER2	Gene	7804
37333406	7	11	Dab1	Gene	1600
37333406	40	44	pTau	Chemical	-
37333406	53	70	neurodegeneration	Disease	MESH:D019636
37333406	74	102	sporadic Alzheimer's disease	Disease	MESH:D000544
37333406	116	144	Sporadic Alzheimer's disease	Disease	MESH:D000544
37333406	146	149	sAD	Disease	MESH:D000544
37333406	167	180	brain disease	Disease	MESH:D001927
37333406	344	361	neurodegeneration	Disease	MESH:D019636
37333406	373	376	Tau	Gene	4137
37333406	453	456	sAD	Disease	MESH:D000544
37333406	495	501	humans	Species	9606
37333406	502	505	Tau	Gene	4137
37333406	560	566	ApoER2	Gene	7804
37333406	567	571	Dab1	Gene	1600
37333406	607	613	ApoER2	Gene	7804
37333406	661	673	degeneration	Disease	MESH:D009410
37333406	718	724	Reelin	Gene	5649
37333406	725	729	ApoE	Gene	348
37333406	730	734	ApoJ	Gene	1191
37333406	735	741	ApoER2	Gene	7804
37333406	742	746	Dab1	Gene	1600
37333406	747	755	P85alpha	Gene	5295
37333406	756	761	LIMK1	Gene	3984
37333406	762	765	Tau	Gene	4137
37333406	766	771	PSD95	Gene	1742
37333406	996	1002	ApoER2	Gene	7804
37333406	1003	1007	Dab1	Gene	1600
37333406	1074	1077	sAD	Disease	MESH:D000544
37333406	1156	1159	sAD	Disease	MESH:D000544
37333406	1181	1187	ApoER2	Gene	7804
37333406	1213	1219	ApoER2	Gene	7804
37333406	1220	1224	Dab1	Gene	1600
37333406	1379	1385	ApoER2	Gene	7804
37333406	1480	1484	pTau	Disease	
37333406	1570	1573	sAD	Disease	MESH:D000544
37333406	1662	1668	ApoER2	Gene	7804
37333406	1813	1816	MCI	Disease	
37333406	1821	1824	sAD	Disease	MESH:D000544
37333406	1880	1898	cognitive deficits	Disease	MESH:D003072
37333406	1928	1932	Dab1	Gene	1600
37333406	2052	2058	ApoER2	Gene	7804
37333406	2097	2101	ApoE	Gene	348
37333406	2102	2106	ApoJ	Gene	1191
37333406	2229	2235	ApoER2	Gene	7804
37333406	2236	2240	Dab1	Gene	1600
37333406	2340	2344	pTau	Disease	
37333406	2456	2462	ApoER2	Gene	7804
37333406	2463	2467	Dab1	Gene	1600
37333406	2507	2511	pTau	Chemical	-
37333406	2529	2546	neurodegeneration	Disease	MESH:D019636
37333406	2550	2553	sAD	Disease	MESH:D000544
37333406	2759	2762	sAD	Disease	MESH:D000544
37333406	Association	MESH:D000544	7804
37333406	Association	1600	7804
37333406	Association	1600	4137
37333406	Association	MESH:D009410	4137
37333406	Association	MESH:D019636	1600
37333406	Association	4137	7804
37333406	Association	MESH:D000544	4137
37333406	Association	MESH:D019636	7804
37333406	Association	MESH:D000544	1600
37333406	Association	MESH:D009410	7804

